RINALDI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 2.714
EU - Europa 870
AS - Asia 797
SA - Sud America 138
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 65
OC - Oceania 1
Totale 4.675
Nazione #
US - Stati Uniti d'America 2.652
SG - Singapore 281
VN - Vietnam 169
IT - Italia 155
RU - Federazione Russa 150
CN - Cina 138
BR - Brasile 116
DE - Germania 90
UA - Ucraina 87
IE - Irlanda 80
SE - Svezia 79
HK - Hong Kong 68
CI - Costa d'Avorio 62
FI - Finlandia 59
FR - Francia 51
GB - Regno Unito 42
TR - Turchia 42
IN - India 31
CA - Canada 28
DK - Danimarca 24
PL - Polonia 18
BD - Bangladesh 14
KR - Corea 14
AR - Argentina 12
NL - Olanda 12
JP - Giappone 10
MA - Marocco 10
ZA - Sudafrica 10
IQ - Iraq 6
ES - Italia 5
LT - Lituania 5
MX - Messico 5
CR - Costa Rica 4
GP - Guadalupe 4
PR - Porto Rico 4
SV - El Salvador 4
AZ - Azerbaigian 3
BE - Belgio 3
CO - Colombia 3
HN - Honduras 3
ID - Indonesia 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
PK - Pakistan 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AL - Albania 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
GT - Guatemala 2
MY - Malesia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.613
Città #
Ashburn 469
Chandler 236
Singapore 202
Fairfield 168
Jacksonville 136
Dublin 80
San Jose 80
Seattle 80
New York 76
Wilmington 73
Houston 71
Hong Kong 68
Woodbridge 67
Boardman 65
Los Angeles 65
Abidjan 62
Dallas 58
Council Bluffs 57
Des Moines 57
Ho Chi Minh City 57
Cambridge 50
Beijing 41
Hanoi 39
Munich 39
The Dalles 37
Princeton 35
Turku 34
Ann Arbor 31
Lawrence 30
Lauterbourg 29
San Mateo 29
Moscow 24
Milan 22
Turin 21
Santa Clara 18
Washington 18
Buffalo 16
Warsaw 16
Irving 15
São Paulo 15
Helsinki 14
Phoenix 14
Chicago 13
Montreal 13
Orem 13
San Diego 13
Chennai 12
Da Nang 11
Brooklyn 10
London 10
Poplar 10
Rome 10
Rio de Janeiro 9
Tokyo 9
Amsterdam 8
Atlanta 8
Hefei 8
Johannesburg 8
Norwalk 8
Shanghai 8
Columbus 7
Denver 7
Haiphong 7
Ancona 6
Pune 6
Toronto 6
Ankara 5
Boston 5
Falls Church 5
Miano 5
Saint Louis 5
Avon 4
Baghdad 4
Bến Tre 4
Frankfurt am Main 4
San José 4
San Salvador 4
Baku 3
Can Tho 3
Castelraimondo 3
Charlotte 3
Cleveland 3
Guangzhou 3
Jiaxing 3
Kilburn 3
Maceió 3
Miami 3
Montegiorgio 3
Nairobi 3
North Bergen 3
San Francisco 3
Stockholm 3
Tampa 3
Tashkent 3
Vũng Tàu 3
Wuhan 3
Anápolis 2
Baytown 2
Bengaluru 2
Brussels 2
Totale 3.148
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 264
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases 195
The role of an immune checkpoint score in resected non-small cell lung cancer patients' prognosis 176
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 173
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 173
Electrolyte disorders in cancer patients: a systematic review 170
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 168
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 166
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 163
Managing hyponatremia in lung cancer: latest evidence and clinical implications 160
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 160
High CTLA-4 expression correlates with poor prognosis in thymoma patients 160
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 159
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 159
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 156
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 154
Systemic treatment for lung carcinoids: from bench to bedside 154
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 154
Hyponatremia in cancer patients: Time for a new approach 149
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 147
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 145
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 142
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 141
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 140
The Formidable Metamorphosis of the Salamander’s Wool: Asbestos from Eternal Material to Awful Pathologies 129
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 127
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 126
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 123
Treatment of advanced small cell lung cancer 121
Lung cancer prognosis: Can histological patterns and morphological features have a role in the management of lung cancer patients? 121
Totale 4.675
Categoria #
all - tutte 21.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022160 0 0 0 0 4 25 7 14 19 26 26 39
2022/2023622 34 86 36 72 20 113 0 43 142 0 61 15
2023/2024371 52 7 32 14 49 110 4 41 0 15 0 47
2024/2025603 84 49 16 3 36 31 56 26 102 37 79 84
2025/20261.576 145 77 54 212 196 139 267 153 106 131 26 70
2026/2027360 51 99 54 148 8 0 0 0 0 0 0 0
Totale 4.675